[1]刘 洋,郭璐萱,郝 娜.基于足细胞的保护作用探讨中医药治疗膜性肾病作用机制的实验研究进展[J].陕西中医,2023,(5):674-677.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.033]
　LIU Yang,GUO Luxuan,HAO Na.Experimental research progress on the mechanism of traditional Chinese medicine in the treatment of membranous nephropathy based on the protective effect of podocytes[J].,2023,(5):674-677.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.033]
点击复制

基于足细胞的保护作用探讨中医药治疗膜性肾病作用机制的实验研究进展
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年5期
页码:
674-677
栏目:
综 述
出版日期:
2023-05-05

文章信息/Info

Title:
Experimental research progress on the mechanism of traditional Chinese medicine in the treatment of membranous nephropathy based on the protective effect of podocytes
作者:
刘 洋1; 2 ; 郭璐萱1; 2; 郝 娜1; 2
(1.天津中医药大学第一附属医院,天津 300381; 2.国家中医针灸临床医学研究中心,天津 300381)
Author(s):
LIU Yang; GUO Luxuan; HAO Na
(First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300381,China)
关键词:
膜性肾病;  足细胞;  病理特征;  信号通路;  凋亡基因
Keywords:
Membranous nephropathy;  Podocytes;  Pathological features;  Signaling pathways;  Apoptosis genes
分类号:
R 692.2
DOI:
DOI:10.3969/j.issn.1000-7369.2023.05.033
文献标志码:
A
摘要:
基于足细胞的保护作用探讨中医药治疗膜性肾病作用机制的实验研究进展。膜性肾病的主要病理特征表现为肾小球足细胞上皮下免疫复合物沉积及肾小球基底膜和足细胞损伤。中医药可通过下调PI3K/AKT/mTOR、TLR4/NF-κB、ERK/cPLA2、TGF-β1/Smad等足细胞相关信号通路表达,上调AMPK/mTOR足细胞相关信号通路表达,提升Nephrin、Podocin等足细胞相关蛋白的含量及调控足细胞相关凋亡基因(Bcl-2和Bax)的表达从而减轻蛋白尿,降低炎症因子和改善肾功能和脂质代谢,提升血清白蛋白含量,减轻肾脏纤维化和足细胞损伤,进而延缓肾脏病的进展。作者就近五年来中医药基于足细胞的保护作用治疗膜性肾病的基础实验研究进展展开综述,以期对临床膜性肾病的治疗提供参考。
Abstract:
This paper reviews the experimental research progress on the mechanism of traditional Chinese medicine in the treatment of membranous nephropathy based on the protective effect of podocytes.The main pathological features of membranous nephropathy are the deposition of subcutaneous immune complexes on glomerular podocytes and the injury of glomerular basement membrane and podocytes.Traditional Chinese medicine can down-regulate the expression of PI3K/AKT/mTOR,TLR4/NF-κB,ERK/cPLA2,TGF-β1/Smad and other podocytes related signaling pathways,and up-regulate the expression of AMPK/mTOR podocytes related signaling pathways.Increase the content of podocytes related proteins such as Nephrin and Podocin and regulate the expression of podocytes related apoptosis genes(Bcl-2 and Bax)to reduce proteinuria,reduce inflammatory factors,improve renal function and lipid metabolism,increase serum albumin content,reduce renal fibrosis and podocytes injury,and then delay the progression of kidney disease.In order to provide reference for clinical treatment of membranous nephropathy,this paper reviews the experimental research progress of traditional Chinese medicine based on the protective effect of podocytes in the treatment of membranous nephropathy in the past five years.

参考文献/References:

[1] Cai Q,Hendricks AR.Membranous nephropathy:A ten-year journey of discoveries[J].Seminars in Diagnostic Pathology,2020,37(3):116-120.
[2] Cattran DC,Brenchley PE.Membranous nephropathy:Integrating basic science into improved clinical management[J].Kidney Int,2017,91(3):566-574.
[3] Dong D,Fan T,Wang Y,et al.Relationship between renal tissues phospholipase A2 receptor and its serum antibody and clinical condition and prognosis of idiopathic membranous nephropathy:A meta-analysis[J].BMC Nephrology,2019,20(1):444.
[4] 艾丽曼,王 顺.雷公藤多苷联合小剂量激素治疗特发性膜性肾病疗效研究[J].陕西中医,2022,43(6):712-714.
[5] 张晓凤,程小红,田 耘,等.特发性膜性肾病中医证候分布与临床病理分期的相关性研究[J].陕西中医,2017,38(8):1051-1053.
[6] 高 飞,王泽泽.中药复方辅助治疗膜性肾病的系统评价和Meta分析[J].天津中医药,2022,39(1):63-70.
[7] 孙 倩,李姗姗,杨少宁,等.中医药调控Notch信号通路防治肾脏疾病研究进展[J].中国实验方剂学杂志,2021,27(24):227-234.
[8] Lahiri V,Hawkins WD,Klionsky DJ.Watch what you self-eat:Autophagic mechanisms that modulate metabolism[J].Cell Metabolism,2019,29(4):803-826.
[9] 何依玲,胡 珏.白藜芦醇对膜性肾病大鼠的肾保护作用[J].中国临床药理学杂志,2021,37(6):707-709.
[10] 高 飞,王泽泽,杨 冰,等.加味升降散对膜性肾病大鼠PI3K/AKT/mTOR信号通路及自噬的影响[J].中国实验方剂学杂志,2020,26(20):30-36.
[11] 林 劲,欧阳辉,梁春玲,等.白芍总苷对膜性肾病大鼠肾脏保护作用及自噬的影响[J].中药新药与临床药理,2019,30(9):1025-1031.
[12] 赵 黎,刘 巍,杨 涛,等.五味子乙素联合泼尼松调节PI3K/AKT信号通路改善大鼠膜性肾病研究[J].药物评价研究,2021,44(6):1247-1252.
[13] 贾世艳,仲启明,司瑞花,等.基于转录组测序技术探讨复方蛇龙胶囊治疗膜性肾病大鼠潜在机制[J].陕西中医,2022,43(7):842-846.
[14] Zhang L,Liu L,Bai M,et al.Hypoxia-induced HE4 in tubular epithelial cells promotes extracellular matrix accumulation and renal fibrosis via NF-κB[J].The Faseb Journal,2020,34(2):2554-2567.
[15] 高 飞,王泽泽,杨 冰,等.基于TLR4/NF-κB信号通路探讨加味升降散对膜性肾病大鼠肾组织纤维化的影响[J].中国实验方剂学杂志,2021,27(6):46-54.
[16] 邵建彬,王 霞,徐华洲,等.芪苓通络方抑制TLR4/MyD88/NF-κB信号通路改善特发性膜性肾病大鼠肾损伤[J].中国实验方剂学杂志,2022,28(4):100-108.
[17] 樊红卫,薛海燕,姚建辉,等.川芎嗪通过抑制NF-κB信号通路减轻膜性肾病大鼠的炎症反应和肾脏损伤[J].药物评价研究,2021,44(8):1666-1673.
[18] 丁 秀,袁 军,邹新蓉,等.基于ERK/cPLA2信号通路探讨膜肾方对膜性肾病大鼠模型的干预作用及其机制[J].时珍国医国药,2021,32(10):2334-2336.
[19] 李 莉,张琼果.基于胞外信号调节激酶/胞浆型磷脂酶A2信号通路分析川芎嗪对膜性肾病大鼠肾保护作用[J].中国临床药理学杂志,2020,36(12):1665-1668.
[20] 叶文冲,王瑞忠,曾桐春,等.组分配伍四逆汤抑制ERK/cPLA2信号通路改善大鼠膜性肾病[J].药物评价研究,2018,41(6):1021-1025.
[21] 郭晓媛,雷 明,宋子威,等.扶正祛风方通过TGF-β1/Smad信号通路抑制膜性肾病大鼠足细胞转分化的机制[J].中国实验方剂学杂志,2021,27(8):57-65.
[22] 陈正涛,高 泓,张 愿,等.足细胞自噬与糖尿病肾病的关系及中医药调控研究进展[J].中国实验方剂学杂志,2022,28(7):227-238.
[23] 郝文霞,高 飞,赵 方,等.降脂通络软胶囊调控AMPK/mTOR信号通路对膜性肾病大鼠自噬的影响[J].中药药理与临床,2021,37(4):148-153.
[24] 张欣欣,高 飞,陈素枝,等.益肾通络方对膜性肾病大鼠的肾保护作用及对AMPK/mTOR/ULK1信号通路的影响[J].中国实验方剂学杂志,2021,27(12):57-66.
[25] 褚宇东,李荣山,田 渊,等.阿司匹林阻断高脂血症诱导的足细胞内质网应激的机制[J].中华肾脏病杂志,2020,35(2):139-140.
[26] 周晓丽,张 倩,钱智勇.高脂血症动物模型肾功能损伤机制及干预研究进展[J].实验动物与比较医学,2022,42(3):213-219.
[27] 许晓丽,何志婷.Exocyst敲减对肾足细胞缺失及功能紊乱的影响[J].陕西医学杂志,2020,49(1):3-6,15.
[28] 鲁 欢,张礼财,宋 超,等.温阳利水方对阳离子化牛血清白蛋白致膜性肾病大鼠足细胞的保护作用[J].广州中医药大学学报,2021,38(1):116-122.
[29] 杨丽影,杨巧芳,薛 昕,等.加味过敏煎不同拆方组分对膜性肾病大鼠足细胞裂孔膜蛋白Nephrin的影响[J].中华中医药杂志,2017,32(12):5562-5565.
[30] 马 赟,胡海涛.宣通三焦、活血通络方对膜性肾病大鼠肾保护作用及肾脏组织中Nephrin、NEPH1表达的影响[J].现代中西医结合杂志,2021,30(28):3100-3106.
[31] 孔怡然,杨凤文,任美芳,等.益肾通络方对膜性肾病大鼠足细胞表型转化的影响[J].中华中医药学刊,2020,38(4):233-236,284-286.
[32] 田瑞娜,周悦欣,安晓飞.补肾活血降浊法治疗2型糖尿病肾病蛋白尿和肾功能减退研究进展[J].山东中医杂志,2021,40(11):1277-1281.
[33] 陈玲玲,左 扬,冯 源,等.益气活血化瘀汤对膜性肾病大鼠肾脏组织Podocin表达的影响[J].中国中医急症,2018,27(11):1912-1916.
[34] 蔡小凡,邓跃毅,钟逸斐,等.参芪膜肾颗粒对膜性肾病大鼠的治疗作用及机制初探[J].中国中西医结合肾病杂志,2017,18(10):852-855.
[35] 冯 喆,雷根平,王 婷,等.芪地固肾片对膜性肾病大鼠的肾保护作用[J].中成药,2021,43(11):3166-3171.
[36] 关 冰,田 雪,李伟男,等.健脾益肾活血方对膜性肾病大鼠肾组织Nephrin和Podocin表达的影响[J].现代中西医结合杂志,2022,31(6):731-736.
[37] 郭小云,李洪钧,李 荣.丹红注射液对膜性肾病模型大鼠足细胞跨膜蛋白表达的影响[J].国际中医中药杂志,2019,41(8):836-842.

相似文献/References:

[1]贾世艳,仲启明,司瑞花,等.基于转录组测序技术探讨复方蛇龙胶囊治疗膜性肾病大鼠潜在机制[J].陕西中医,2022,(7):842.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.006]
　JIA Shiyan,ZHONG Qiming,SI Ruihua,et al.Transcriptomic analysis exploring the molecular mechanisms of Shelong capsule in membranous nephropathy in rats[J].,2022,(5):842.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.006]
[2]玉山江 ·艾克木,哈丽达·木沙,王晓腾,等.西红康对2型糖尿病肾病大鼠肾足细胞功能的影响[J].陕西中医,2023,(1):16.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.004]
　AIKEMU·Yushanjiang,MUSHA·Halida,WANG Xiaoteng,et al.Effects of Xihongkang on renal podocyte function in rats with type 2 diabetic nephropathy[J].,2023,(5):16.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.004]
[3]刘华亭,郑博文,陈 晨,等.基于NLRP3/Caspase-1/IL-1β信号通路探讨复方蛇龙胶囊对膜性肾病大鼠的作用[J].陕西中医,2023,(6):709.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.006]
　LIU Huating,ZHENG Bowen,CHEN Chen,et al.Effect of compound Shelong capsule on membranous nephropathy rats based on NLRP3/Caspase-1/IL-1β signaling pathway[J].,2023,(5):709.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.006]
[4]崔方强,王悦芬,孟 元,等.保肾通络方含药血清对高糖培养足细胞Nephrin、Desmin蛋白表达及细胞凋亡的影响[J].陕西中医,2023,(8):995.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.001]
　CUI Fangqiang,WANG Yuefen,MENG Yuan,et al.Effect of drug-containing serum of Baoshen Tongluo recipe on Nephrin and Desmin expression and apoptosis of podocyte in high-glucose environment[J].,2023,(5):995.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.001]
[5]张 磊,刘超楠,韩秀涛,等.雷公藤乙素对糖尿病肾病足细胞损伤自噬作用及免疫代谢的影响[J].陕西中医,2023,(8):1021.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.006]
　ZHANG Lei,LIU Chaonan,HAN Xiutao,et al.Effect of triptolide on autophagy and immunity of DKD podocyte injury[J].,2023,(5):1021.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.006]
[6]洪 佳,陈 勇.自噬与糖尿病肾病的关系及中医药干预机制研究进展[J].陕西中医,2024,(4):574.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.032]
　HONG Jia,CHEN Yong.Research progress on the relationship between autophagy and diabetes nephropathy and the intervention mechanism of traditional Chinese medicine[J].,2024,(5):574.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.032]
[7]魏晓菲,王晨丹.雷公藤甲素调控NLRP3/GSDMD/IL-1β途径改善六价铬对足细胞损伤的机制研究[J].陕西中医,2024,(9):1172.[doi:DOI:10.3969/j.issn.1000-7369.2024.09.004]
　WEI Xiaofei,WANG Chendan.Study on the mechanism of triptolide regulating NLRP3/GSDMD/IL-1β pathway to improve podocyte injury induced by Cr(Ⅵ)[J].,2024,(5):1172.[doi:DOI:10.3969/j.issn.1000-7369.2024.09.004]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金青年基金资助项目(81904141); 湖北陈孝平科技发展基金会专项基金资助项目(CXPJJH122003-09)
更新日期/Last Update: 2023-05-09